Cross Country Healthcare Q4 Earnings Call Highlights

Core Viewpoint - Cross Country Healthcare is experiencing a stabilization in the healthcare staffing market, particularly in travel staffing, with expectations for growth in 2026 despite a challenging 2025 due to a terminated merger [3][2]. Financial Performance - Q4 revenue was $237 million, down 24% year-over-year, and full-year revenue was $1.05 billion, down 22% [5][7]. - Adjusted EBITDA for Q4 was $4 million, with a full-year adjusted EBITDA of $27 million, reflecting margins of 1.7% and 2.5% respectively [9][5]. - The company recorded a $78 million non-cash impairment charge related to the terminated merger, impacting below-EBITDA results [10][5]. Market Outlook - The company expects travel staffing to be flat to slightly up sequentially, with Travelers On Assignment projected to grow each month into Q2 [2][6]. - Management anticipates a revenue run rate exceeding $1 billion by the end of 2026, with an adjusted EBITDA margin of 4% to 5% [4][22]. Operational Strategy - The company is focusing on technology and operational efficiency, with plans to expand its workforce intelligence platform, Intellify, into new staffing markets [16][17]. - Cross Country Healthcare aims to enhance recruiter productivity and back-office efficiency through automation and AI initiatives [17][18]. Segment Performance - Travel staffing revenue declined 30% year-over-year, while home-based staffing grew 34% year-over-year, indicating a shift in demand [11][14]. - Education staffing revenue increased 48% sequentially, with expectations for growth in 2026 [13][12]. Balance Sheet and Shareholder Actions - The company ended the quarter with $109 million in cash and no debt, having repurchased over 1.3 million shares recently [4][19]. - Management believes the stock does not reflect its underlying value and anticipates further share repurchases [20].